Nancy Denyes A Tyr Pharma Inc (LIFE) insider trading activity

LIFE Quotes by TradingView

Nancy Denyes is General Counsel of aTYR PHARMA INC. Currently has a direct ownership of 26,555 shares of LIFE, which is worth approximately $49,392. The most recent transaction as insider was on Feb 04, 2025, when has been sold 899 shares (Common Stock) at a price of $3.78 per share, resulting in proceeds of $3,398. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.6K
19.26% 3M change
79.83% 12M change
Total Value Held $49,392

NANCY DENYES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 04 2025
SELL
Open market or private sale
$3,398 $3.78 p/Share
899 Reduced 3.27%
26,555 Common Stock
Feb 03 2025
BUY
Exercise of conversion of derivative security
-
2,687 Added 8.91%
27,454 Common Stock
Jun 05 2024
BUY
Open market or private purchase
$9,300 $1.86 p/Share
5,000 Added 18.34%
22,267 Common Stock
Feb 05 2024
BUY
Exercise of conversion of derivative security
-
2,688 Added 15.4%
14,767 Common Stock
Feb 03 2023
BUY
Exercise of conversion of derivative security
-
2,688 Added 27.52%
7,079 Common Stock
ND

Nancy Denyes

General Counsel
San Diego, CA

Track Institutional and Insider Activities on LIFE

Follow aTYR PHARMA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LIFE shares.

Notify only if

Insider Trading

Get notified when an A Tyr Pharma Inc insider buys or sells LIFE shares.

Notify only if

News

Receive news related to aTYR PHARMA INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LIFE